Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) Stock News & Analysis
Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) is a company in the Health Care sector, listed on the NASDAQ. This page collects all Alpha Stocks Insight coverage of ARQT: earnings reports, analyst actions, and company news, updated as new articles are published. 1 article since May 6, 2026.
ARQT Coverage -- 1 Article
ARQT Q1 2026: ZORYVE Revenue Hits $105.4M, Up 65% YoY as EPS Misses Estimate
Arcutis Biotherapeutics posted strong ZORYVE revenue growth of 65% YoY in Q1 2026, though EPS of $(0.09) fell short of the $(0.06) consensus.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.